Delta checks based on individual patients' data

doi:10.3969/j.issn.1673-8640.2017.01.015

Abstract

Abstract:

Risks are inherent in each step of whole testing process. Delta checks based on individual patients' data are methods for mitigating these risks. Delta checks can be used as a complementary tool for traditional laboratory quality control to determine issues that quality control materials may not address. It can be applied into different phases in whole testing process,including determining misidentified and mishandled specimens,true patients' changes,instrumentation and personal errors,as well as the evaluation of point-of-care testing（POCT）. The review introduces the application of delta checks in POCT and pre-examination,intra-examination and post-examination phases,including selecting candidate analytes,establishing monitor parameters,setting limits and the evaluation of usefulness,hoping to provide a reference for clinical laboratories.

Key words: Quality control, Quality assurance, Delta checks, Laboratory errors

CLC Number:

R446.1

FEI Yang, WANG Wei, WANG Zhiguo. Delta checks based on individual patients' data[J]. Laboratory Medicine, 2017, 32(1): 64-68.

References 17

1	CEMBROWSKI G S,CAREY R N.Laboratory quality management:QC and QA[M]. Chicago:ASCP,1989:133-164.
2	NOSANCHUK J S,GOTTMANN A W.CUMS and delta checks. A systematic approach to quality control[J]. Am J Clin Pathol,1974,62(5):707-712.
3	LADENSON J H.Patients as their own controls: use of the computer to identify "laboratory error"[J]. Clin Chem,1975,21(11):1648-1653.
4	SHER P P.An evaluation of the detection capacity of a computer-assisted real-time delta check system[J]. Clin Chem,1979,25(6):870-872.
5	IIZUKA Y,KUME H,KITAMURA M.Multivariate delta check method for detecting specimen mix-up[J]. Clin Chem,1982,28(11):2244-2248.
6	DUFOUR D R,CRUSER D L,BUTTOLPH T,et al.The clinical significance of delta checks[J]. Am J Clin Pathol,1998,110:531.
7	KIM J W,KIM J Q,KIM S I.Differential application of rate and delta check on selected clinical chemistry tests[J]. J Korean Med Sci,1990,5(4):189-195.
8	STRATHMANN F G,BAIRD G S,HOFFMAN N G.Simulations of delta check rule performance to detect specimen mislabeling using historical laboratory data[J]. Clin Chim Acta,2011,412(21-22):1973-1977.
9	FRASER C G.Biological variation: from principles to practice[M]. Washington DC:AACC, 2001:67-90.
10	RICOS C,ALVAREZ V,CAVA F,et al.Current databases on biological variation:pros,cons and progress[J]. Scand J Clin Lab Invest,1999,59(7):491-500.
11	LACHER D A,HUGHES J P,CARROLL M D.Estimate of biological variation of laboratory analytes based on the third national health and nutrition examination survey[J]. Clin Chem,2005,51(2):450-452.
12	KATZMANN J A,SNYDER M R,RAJKUMAR S V,et al.Long-term biological variation of serum protein electrophoresis M-spike,urine M-spike,and monoclonal serum free light chain quantification:implications for monitoring monoclonal gammopathies[J]. Clin Chem,2011,57(12):1687-1692.
13	HARRIS E K.Effects of intra- and interindividual variation on the appropriate use of normal ranges[J]. Clin Chem,1974,20(12):1535-1542.
14	HARRIS E K.Statistical aspects of reference values in clinical pathology[J]. Prog Clin Pathol,1981,8:45-66.
15	SAMPSON M L,REHAK N N,SOKOLL L J,et al.Time adjusted sensitivity analysis: a new statistical test for the optimization of delta check rules[J]. J Clin Ligand Assay,2007,30(1-2):44-54.
16	Clinical and Laboratory Standards Institute. Verification of comparability of patient results within one health care system[S]. C54-A-IR,CLSI,2012.
17	王治国. 临床检验质量控制技术[M]. 3版. 北京:人民卫生出版社, 2014:360-364.

[1]	MENG Xi, WEI Zhen, BAI Jianhua, HAO Xiaoke, ZENG Xianfei. Application of EWMA，HIQC and autoverification in primary medical institutions [J]. Laboratory Medicine, 2023, 38(9): 884-889.
[2]	CHEN Naihan, SA Yalian. Overview of detection methods for Mycoplasma in cell preparations [J]. Laboratory Medicine, 2022, 37(7): 684-687.
[3]	ZHANG Chen, LI Ting, MENG Qinghao, XIE Nan, ZHANG Weimin, ZHAO Fei, LI Min, GAO Xuan, YANG Sijie. Performance evaluation of glycerol as stabilizer for the preparation of seminal plasma biochemical quality control products [J]. Laboratory Medicine, 2022, 37(12): 1200-1203.
[4]	FANG Huiling, CHEN Ziqi, ZHU Yuqing. Performance of antigen test for SARS-CoV-2 and related research progress [J]. Laboratory Medicine, 2022, 37(11): 1098-1103.
[5]	KAN Lijuan, ZHANG Lijun, ZHANG Xiuming. Interpretation and application of 15 quality control indicators in clinical laboratories [J]. Laboratory Medicine, 2022, 37(10): 907-914.
[6]	YANG Fan, DONG Danfeng, LU Yide. Application of patient-based real-time quality control using exponentially weighted moving average method on internal quality control procedures for serum ion items [J]. Laboratory Medicine, 2021, 36(9): 962-968.
[7]	ZHANG Pengyin, QUAN Jing, WANG Xueliang, XIAO Yanqun, BAO Yun. External quality assessment of irinotecan-related metabolism genotyping in Shanghai [J]. Laboratory Medicine, 2021, 36(8): 875-879.
[8]	ZHANG Hongwei, ZHAO Zhengjie, ZHAO Yan, LI Haisheng, LI Xiufang, QIAN Jing, GUO Chong. Application of Unity Real Time software to establish individual quality control rules for blood cell analysis [J]. Laboratory Medicine, 2021, 36(7): 749-752.
[9]	ZHENG Cuiling, WANG Li, CHENG Yan, CUI Wei. Fresh blood comparison program in daily internal quality control of hematology analyzers [J]. Laboratory Medicine, 2021, 36(6): 662-666.
[10]	GE Danhong, TANG Liping, OU Yuanzhu, YU Xiaoxuan, LIU Wenbin, LIN Feiran, GONG Jingkai, ZHU Yuqing. Assessment of internal quality control plan for microfluidic chip POCT [J]. Laboratory Medicine, 2021, 36(6): 674-678.
[11]	ZHAO Ran, LIU Wenbin, LIN Feiran, GONG Jingkai, YU Xiaoxuan, GE Danhong, TANG Liping, OU Yuanzhu. Internal quality control and evaluation of blood gas analysis based on Westgard sigma rules [J]. Laboratory Medicine, 2021, 36(5): 544-548.
[12]	WEN Liangxue, ZHANG Lanyi, SU Li, WANG Mingfen, LIU Yongsheng. Internal quality control of HBV DNA determination in blood center nucleic acid laboratory [J]. Laboratory Medicine, 2021, 36(4): 437-440.
[13]	CHEN Rong, ZHANG Minmin, XIA Qihang, QIAN Chengkai, CUI Lin, LIU Xuejie, XU Rong, WANG Qingzhong, GE Ping, HUANG Weigang, WANG Jinghua. External quality assessment of fungal culture identification and in vitro drug sensitivity test in Shanghai [J]. Laboratory Medicine, 2021, 36(4): 441-443.
[14]	JIANG Lingli, ZHU Jun, YANG Xue, LOU Jiao, WANG Qing. Analysis of quality management of medical laboratory in Shanghai medical institutions [J]. Laboratory Medicine, 2021, 36(3): 332-336.
[15]	FANG Huiling, GE Danhong, ZHU Yuqing, ZHU Lingfeng, ZHAO Xiaojun, CHEN Ziqi, WANG Zimeng. Analysis on the external quality assessment results for 25-hydroxyvitamin D of Shanghai from 2015 to 2019 [J]. Laboratory Medicine, 2021, 36(2): 219-224.